Academic article

• Goto, Tatsunori; Okamura, Hiroshi; Ikeda, Takashi et al. (2025). Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE study. (external link)
• Vonk, Christian M.; Grob, Tim; Rijken, Melissa et al. (2025). Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML. (external link)
• Caulier, Benjamin William; Joaquina, Sandy; Gelebart, Pascal Francois et al. (2024). CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia. (external link)
• Kleftogiannis, Dimitrios; Gavasso, Sonia; Tislevoll, Benedicte Sjo et al. (2024). Automated cell type annotation and exploration of single-cell signaling dynamics using mass cytometry. (external link)
• Maas, Niek G. van der; Versluis, Jurjen; Nasserinejad, Kazem et al. (2024). Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial. (external link)
• Grønvold, Bjørn Christer Linder; Ali, Maryan Mohamed; Myklebust, Tor Åge et al. (2024). Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors. (external link)
• Chen, Yi-Bin; Mohty, Mohamad; Zeiser, Robert et al. (2024). Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. (external link)
• Vo, Camilla Dao; Myhre, Anders Eivind; Abrahamsen, Ingerid Weum et al. (2023). Allogen stamcelletransplantasjon hos voksne 2015–21. (external link)
• Fløisand, Yngvar; Remberger, Mats; Bigalke, Iris et al. (2023). WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy. (external link)
• Grob, Tim; Sanders, Mathijs A.; Vonk, Christian M. et al. (2023). Prognostic Value of FLT3 -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia. (external link)
• Andersen, Aram Nikolai; Brodersen, Andrea M; Duran, Pilar Ayuda et al. (2023). Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling. (external link)
• Tislevoll, Benedicte Sjo; Hellesøy, Monica; Fagerholt, Oda Helen Eck et al. (2023). Early response evaluation by single cell signaling profiling in acute myeloid leukemia. (external link)
• Kleftogiannis, Dimitrios; Tislevoll, Benedicte Sjo; Hellesøy, Monica et al. (2022). Identifying predictors of survival in patients with leukemia using single-cell mass cytometry and machine learning. (external link)
• Tislevoll, Benedicte Sjo; Hellesøy, Monica; Fagerholt, Oda Helen Eck et al. (2022). Early response evaluation by single cell signaling profiling in acute myeloid leukemia. (external link)
• Garcia-Horton, Alejandro; Cyriac, Sunu L.; Gedde-Dahl, Tobias et al. (2022). Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups. (external link)
• Vonk, Christian; Grob, Tim; Sanders, Mathijs et al. (2022). AML-234 Prognostic Value of FLT3-ITD Residual Disease in Acute Myeloid Leukemia. (external link)
• Fløisand, Yngvar; Schroeder, Mark A.; Chevallier, Patrice et al. (2021). A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease. (external link)
• Ali, Maryan Mohamed; Grønvold, Bjørn Christer Linder; Remberger, Mats et al. (2021). Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival. (external link)
• Löwenberg, Bob; Pabst, Thomas; Maertens, Johan et al. (2021). Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: The HOVON-SAKK-132 trial. (external link)
• Quiles-Jiménez, Ana M T; Gregersen, Ida; Segers, Filip et al. (2021). DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis development. (external link)
• Jørgensen, Silje Fjellgård; Buechner, Jochen; Myhre, Anders Eivind et al. (2021). A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT. (external link)
• Remberger, Mats; Tjønnfjord, Geir Erland; Abrahamsen, Ingerid Weum et al. (2021). Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG. (external link)
• Spyridonidis, Alexandros; Labopin, Myriam; Savani, Bipin N. et al. (2020). Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. (external link)
• Berishvili, Ekaterine; Kaiser, Laurent; Cohen, Marie et al. (2020). Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy. (external link)
• Tadele, Dagim Shiferaw; Robertson, Joseph; Crispin, Richard et al. (2020). A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation. (external link)
• Saad, Ayman; Lamb, Lawrence; Wang, Tao et al. (2019). Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. (external link)
• Thomas, Anub Mathew; Gerogianni, Alexandra; McAdam, Martin Berner et al. (2019). Complement component C5 and TLR molecule CD14 mediate heme-induced thromboinflammation in human blood. (external link)
• Sioud, Mouldy; Pettersen, Solveig; Ailte, Ieva et al. (2019). Targeted killing of monocytes/macrophages and myeloid leukemia cells with pro-apoptotic peptides. (external link)
• Sioud, Mouldy; Westby, Phuong; Vasovic, Vlada et al. (2018). Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies. (external link)
• Fløisand, Yngvar; Lazarević, Vladimir Lj.; Maertens, Johan et al. (2018). Safety and effectiveness of vedolizumab in patients with steroid-refractory gastrointestinal acute graft-versus-host disease: A retrospective record review. (external link)
• Danylesko, Ivetta; Bukauskas, Adomas; Paulson, Martin et al. (2018). Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease. (external link)
• Wang, Dong; Fløisand, Yngvar; Myklebust, Camilla Victoria et al. (2017). Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice. (external link)
• Kontro, Mika; Kumar, Anil; Majumder, Muntasir Mamun et al. (2017). HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia. (external link)
• Ringdén, O.; Labopin, M.; Sadeghi, B et al. (2017). What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?. (external link)
• SERVER, ANDRES; Bargalló, Núria; Fløisand, Yngvar et al. (2017). Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation.. (external link)
• Gustavsen, Alice; Skattum, Lillemor; Bergseth, Grete et al. (2017). Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome. (external link)
• Wennström, Lovisa; Edslev, Pernille Wendtland; Abrahamsson, Jonas et al. (2016). Acute myeloid leukemia in adolescents and young adults treated in pediatric and adult departments in the Nordic countries. (external link)
• Barratt-Due, Andreas; Fløisand, Yngvar; Lang, Hilde Elisabeth et al. (2016). Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome.. (external link)
• Torfoss, Dag; Fladhagen, Tone; Holte, Harald et al. (2016). Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial. (external link)
• Fløisand, Yngvar; Lundin, Knut Erik Aslaksen; Lazarevic, Vladimir et al. (2016). Targeting integrin α4β7 in steroid-refractory intestinal graft-versus-host disease. (external link)
• Bremer, Sara; Fløisand, Yngvar; Brinch, Lorentz et al. (2015). Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome after Myeloablative Conditioning. (external link)
• Høyvoll, Liv Ragnhild; Fløisand, Yngvar; Lang, Hilde Elisabeth et al. (2015). Hemophagocytic lymphohistiocytosis in leprosy. (external link)
• Husøy, Magnus Andreas Rognlien; Brinch, Lorentz; Tjønnfjord, Geir Erland et al. (2014). Allogen stamcelletransplantasjon hos voksne 1985-2012. (external link)
• Taraldsrud, Eli; Fevang, Børre; Aukrust, Pål et al. (2014). Common variable immunodeficiency revisited: Normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9. (external link)
• Cesaro, S.; Pillon, M.; Tridello, G. et al. (2013). Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation. (external link)
• Fernandes, Amilton Moreira; Herlofsen, Sarah; Karlsen, Tommy Aleksander et al. (2013). Similar Properties of Chondrocytes from Osteoarthritis Joints and Mesenchymal Stem Cells from Healthy Donors for Tissue Engineering of Articular Cartilage. (external link)
• Holm, Are Martin; Riise, GC; Hansson, L. et al. (2013). Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT. (external link)
• Fløisand, Yngvar; Brinch, Lorentz; Gedde-Dahl, Thobias et al. (2012). Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation. (external link)
• Karlsen, Tommy Aleksander; Mirtaheri, Peyman; Shahdafar, Aboulghassem et al. (2011). Effect of Three-Dimensional Culture and Incubator Gas Concentration on Phenotype and Differentiation Capability of Human Mesenchymal Stem Cells. (external link)
• Sioud, Mouldy; Mobergslien, Anne; Boudabous, Abdellatif et al. (2011). Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. (external link)
• Sioud, Mouldy; Mobergslien, Anne; Boudabous, A. et al. (2010). Evidence for the Involvement of Galectin-3 in Mesenchymal Stem Cell Suppression of Allogeneic T-Cell Proliferation. (external link)
• Tangen, Jon-Magnus; Fløisand, Yngvar; Haukås, Einar et al. (2010). Overlevelse hos voksne med akutt lymfoblastisk leukemi :. (external link)
• Kvale, Espen Østhagen; Fløisand, Yngvar; Lund-Johansen, Fridtjof et al. (2007). Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells. (external link)
• Sioud, Mouldy; Fløisand, Yngvar; Forfang, Lise et al. (2006). Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+progenitor cells along the myeloid lineage. (external link)

Errata

• Tislevoll, Benedicte Sjo; Hellesøy, Monica; Fagerholt, Oda Helen Eck et al. (2023). Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia (Nature Communications, (2023), 14, 1, (115), 10.1038/s41467-022-35624-4). (external link)
• Spyridonidis, Alexandros; Labopin, Myriam; Savani, Bipin N. et al. (2020). Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (Bone Marrow Transplantation, (2020), 55, 6, (1114-1125), 10.1038/s41409-020-0803-y). (external link)
• Zhang, Beibei; Ayuda-Duran, Maria del Pilar; Piechaczyk, Laure Isabelle et al. (2019). GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells. (external link)

Chapter

• Holme, Pål Andre; Ghanima, Waleed; Wik, Hilde Skuterud et al. (2022). Koagulasjonsforstyrrelser. (external link)

Academic literature review

• Bazarbachi, Ali; Bug, Gesine; Brissot, Eolia et al. (2020). Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3internal tandem duplication: A position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. (external link)

Reader opinion piece

• Grønvold, Bjørn Christer Linder; Ali, M.M.; Remberger, M. et al. (2020). HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation. (external link)
• Diep, Phoi Phoi; Melberg, Hans Olav; Brinch, Lorentz et al. (2018). Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway. (external link)
• Holm, Are Martin; Riise, Gerdt C.; Brinch, Lorentz et al. (2013). Lung Transplantation for Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation: Unresolved Questions. (external link)
• Fløisand, Yngvar; Delabie, Jan; Fosså, Alexander et al. (2011). Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia. (external link)

Academic lecture

• Diep, Phoi Phoi; Melberg, Hans Olav; Brinch, Lorentz et al. (2017). Allogeneic hematopoietic stem cell transplantation in Norway 1974-2009: Cost-utility and survival in children and young adults. (external link)

Poster

• Ayuda-Duran, Maria del Pilar; Zhang, B; Piechaczyck, L. et al. (2017). a precision medicin platform for acute myeloid leukemia to help unraveling the molecular addictions of FLT3-ITD-driven AML. (external link)
• Josefsen, Dag; Hetland, Geir; Fløisand, Yngvar et al. (2013). The use of Plerixafor in hard-to-mobilize lymphoma and multiple myeloma patients not only provide sufficient numbers of Pbpcs to proceed to high dose therapy, but also have a positive impact on survival. (external link)

Abstract

• Josefsen, Dag; Hetland, Geir; Fløisand, Yngvar et al. (2013). The use of Plerixafor in hard-to-mobilize lymphoma and multiple myeloma patients not only provide sufficient numbers of Pbpcs to proceed to high dose therapy, but also have a positive impact on survival. (external link)
• Bremer, Sara; Fløisand, Yngvar; Brinch, Lorentz et al. (2013). Pharmacogenetics of busulfan: significant association between GSTA1 genotype, busulfan pharmacokinetics and short term toxicity. (external link)
• Josefsen, Dag; Hetland, Geir; Blystad, Anne Kirsti et al. (2013). Successful use of plerixafor in hard to mobilize patients: following high dose therapy all patients developed fast and sustained engraftment with durable clinical responses. (external link)
• Josefsen, Dag; Hetland, Geir; Blystad, Astrid et al. (2013). SUCCESSFUL USE OF PLERIXAFOR IN HARD TO MOBILIZE PATIENTS - FOLLOWING HIGH DOSE THERAPY ALL PATIENTS DEVELOPED FAST AND SUSTAINED ENGRAFTMENT WITH DURABLE CLINICAL RESPONSES. (external link)
• Bremer, Sara; Fløisand, Yngvar; Bergan, Stein (2013). Genotype Based Dosing May Improve Outcomes After Busulfan Conditioning. (external link)
• Holm, Are Martin; Riise, Gerdt C.; Hansson, Lars et al. (2012). Lung Transplantation for Chronic Graft Versus Host Disease after Allogeneic Stem Cell Transplantation. (external link)
• Heldal, Dag; Brinch, Lorentz; Fløisand, Yngvar et al. (2010). Long-term (>= 5 years) follow-up of a randomized study of allogeneic stem cell transplantation with stem cells from blood or bone marrow. (external link)
• Brinch, Lorentz; Fløisand, Yngvar; Tjønnfjord, Geir Erland et al. (2009). Allogeneic blood stem cell transplants for AML using the Bu4Cy2 regimen in AML: long term experience. (external link)
• Kvale, Espen Østhagen; Fløisand, Yngvar; Lund-Johansen, Fridtjof et al. (2006). Plasmacytoid dendritic cells regulate recall responses by rapid induction of IL-10 in CD4+ memory T cells. (external link)

Doctoral dissertation

• Fløisand, Yngvar; Kvale, Dag (2010). Studies on dendritic cell ontogeny, differentiation and function. (external link)

See a complete overview of publications in Cristin.